Improving Pathways to Care for Patients at High Psychosis Risk in Switzerland: PsyYoung Study Protocol.
ARMS
FEP
early detection
early intervention
pathway to care
protocol
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
12 Jul 2023
12 Jul 2023
Historique:
received:
05
06
2023
revised:
29
06
2023
accepted:
30
06
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Psychotic disorders are one of the main causes of chronic disability in young people. An at-risk mental state (ARMS) is represented by subclinical symptoms that precede the first episode of psychosis (FEP). The PsyYoung project aims to optimize the detection of an ARMS while reducing unnecessary psychiatric treatments. It investigates the effects of service changes on the referrals and outcomes of young people with ARMS or a FEP. Six psychiatric outpatient clinics in three cantons (Basel-Stadt, Vaud, and Geneva) participated in the project. They passed through an implementation phase including service changes and the adaptation of a standardized stepped care model for diagnosis and assessment, in addition to measures for increasing the awareness, networking and training of local professionals. All participating cantons had entered the implementation phase. By March 2023, there were 619 referrals to participating sites. A total of 163 patients (37% FEP and 31% ARMS) and 15 close relatives had participated in individual longitudinal assessments, and 26 patients participated in qualitative interviews. This national collaborative project addresses the issue of early intervention for emerging psychoses, and creates spaces for fruitful reflections and collaboration in Switzerland. The ultimate aim of PsyYoung is to harmonize clinical practices in early intervention of psychosis on a national level.
Identifiants
pubmed: 37510757
pii: jcm12144642
doi: 10.3390/jcm12144642
pmc: PMC10380609
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Promotion Santé Suisse
ID : 19.313
Références
Psychol Med. 1999 Jan;29(1):199-212
pubmed: 10077308
Eval Rev. 2015 Dec;39(6):527-54
pubmed: 26851256
Br J Psychiatry Suppl. 1989 Nov;(7):49-58
pubmed: 2695141
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Eur Psychiatry. 2015 Mar;30(3):388-404
pubmed: 25749390
Am J Psychiatry. 2002 May;159(5):863-5
pubmed: 11986145
Acta Psychiatr Scand. 1994 Jan;89(1):62-7
pubmed: 7908156
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
Br J Psychiatry Suppl. 2000;(39):s21-7
pubmed: 10945074
Int J Methods Psychiatr Res. 2003;12(2):65-76
pubmed: 12830300
Psychol Assess. 2011 Mar;23(1):80-94
pubmed: 21280954
Child Psychiatry Hum Dev. 2017 Feb;48(1):1-17
pubmed: 27179521
Psychiatry J. 2016;2016:7146341
pubmed: 27314005
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Soc Sci Med. 1988;26(3):327-32
pubmed: 3279521
Transl Psychiatry. 2021 Jan 13;11(1):43
pubmed: 33441556
Rev Epidemiol Sante Publique. 2010 Feb;58(1):33-9
pubmed: 20096515
Early Interv Psychiatry. 2013 Aug;7(3):322-8
pubmed: 23445318
Br J Psychiatry. 2023 Jul;223(1):282-294
pubmed: 37194556
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Affect Disord. 2009 Jan;112(1-3):92-101
pubmed: 18486238
Pharmacoeconomics. 2020 Apr;38(4):413-425
pubmed: 31912325
Schizophr Res. 2004 Jun 1;68(2-3):283-97
pubmed: 15099610
JAMA Psychiatry. 2021 Sep 1;78(9):970-978
pubmed: 34259821
Schizophr Bull. 1986;12(4):578-602
pubmed: 3810065
Schizophr Bull. 2013 Nov;39(6):1296-306
pubmed: 23172003
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Encephale. 2021 Dec;47(6):547-553
pubmed: 33867141
Qual Life Res. 2004 Mar;13(2):299-310
pubmed: 15085902
World Psychiatry. 2023 Feb;22(1):42-43
pubmed: 36640393
Br J Psychiatry. 2015 Sep;207(3):198-206
pubmed: 26329563
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Am J Psychiatry. 1993 Jun;150(6):885-90
pubmed: 8494063
World Psychiatry. 2021 Feb;20(1):75-95
pubmed: 33432766
Ann Gen Psychiatry. 2021 Jan 19;20(1):5
pubmed: 33468180
JAMA Psychiatry. 2013 Jan;70(1):107-20
pubmed: 23165428
PLoS One. 2017 May 4;12(5):e0176218
pubmed: 28472162
Schizophr Bull. 2012 Nov;38(6):1288-96
pubmed: 22516147
Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71
pubmed: 16343296
Behav Res Ther. 1998 Apr;36(4):455-70
pubmed: 9670605
Early Interv Psychiatry. 2023 Apr 10;:
pubmed: 37037927
Biol Psychiatry. 2004 Sep 1;56(5):301-7
pubmed: 15336511
Rev Med Suisse. 2021 Sep 22;17(751):1597-1601
pubmed: 34550651
Lab Chip. 2014 Jun 21;14(12):1966-86
pubmed: 24806093
J Clin Psychol. 1995 Sep;51(5):632-5
pubmed: 8801239
PLoS One. 2016 Jul 08;11(7):e0158678
pubmed: 27392018
Arch Gen Psychiatry. 1985 Jul;42(7):696-702
pubmed: 4015311
World Psychiatry. 2017 Oct;16(3):251-265
pubmed: 28941089
Acta Psychiatr Scand. 2000 Apr;101(4):323-9
pubmed: 10782554
J Pers Assess. 1990 Winter;55(3-4):610-7
pubmed: 2280326
Epidemiol Psychiatr Sci. 2022 Jan 19;31:e9
pubmed: 35042573
Drug Alcohol Rev. 2003 Sep;22(3):309-15
pubmed: 15385225
JAMA Psychiatry. 2016 Dec 01;73(12):1260-1267
pubmed: 27784037